Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Gradishar

Showing results (91-100 of 195) with videos related to

Pageof 20
Sort By:
Clinical Breast Cancer|June 26, 2012
Phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: final analysis of overall survivalWilliam J Gradishar, Dimitry Krasnojon, Sergey Cheporov, et al.
Trials|July 24, 2013
A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trialJosé Baselga, Frederico Costa, Henry Gomez, et al.
Cancer|February 9, 2022
Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysisRoi Weiser, Efstathia Polychronopoulou, Sandra S Hatch, et al.
Clinical Breast Cancer|December 15, 2010
Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancerKathy S Albain, Lisa Carey, William J Gradishar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Oncology fellows’ career plans, expectations, and well-being: do fellows know what they are getting into?Tait D Shanafelt, Marilyn Raymond, Leora Horn, et al.
Clinical Breast Cancer|November 10, 2005
Single-agent topotecan as first-line chemotherapy in women with metastatic breast cancer: final results of eastern cooperative oncology group trial E8193Antonio C Wolff, Anne O'Neill, M John Kennedy, et al.
Fertility and Sterility|January 18, 2018
Long-term outcomes in cancer patients who did or did not pursue fertility preservationMolly B Moravek, Rafael Confino, Kristin N Smith, et al.
Oncotarget|October 6, 2017
Analyses of selected safety endpoints in phase 1 and late-phase clinical trials of anti-PD-1 and PD-L1 inhibitors: prediction of immune-related toxicitiesRicardo Costa, Rubens B Costa, Sarah M Talamantes, et al.
Clinical & Experimental Metastasis|June 14, 2012
The role of targeted therapy and biomarkers in breast cancer treatmentAlison T Stopeck, Ursa Brown-Glaberman, Hong Yuen Wong, et al.
Annals of Surgical Oncology|July 12, 2021
Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases: An NCDB AnalysisRoi Weiser, Efstathia Polychronopoulou, Waqar Haque, et al.
Pageof 20

Showing results (91-100 of 195) with videos related to

Sort By:
Pageof 20
Clinical Breast Cancer|June 26, 2012
Phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: final analysis of overall survivalWilliam J Gradishar, Dimitry Krasnojon, Sergey Cheporov, et al.
Trials|July 24, 2013
A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trialJosé Baselga, Frederico Costa, Henry Gomez, et al.
Cancer|February 9, 2022
Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysisRoi Weiser, Efstathia Polychronopoulou, Sandra S Hatch, et al.
Clinical Breast Cancer|December 15, 2010
Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancerKathy S Albain, Lisa Carey, William J Gradishar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Oncology fellows’ career plans, expectations, and well-being: do fellows know what they are getting into?Tait D Shanafelt, Marilyn Raymond, Leora Horn, et al.
Clinical Breast Cancer|November 10, 2005
Single-agent topotecan as first-line chemotherapy in women with metastatic breast cancer: final results of eastern cooperative oncology group trial E8193Antonio C Wolff, Anne O'Neill, M John Kennedy, et al.
Fertility and Sterility|January 18, 2018
Long-term outcomes in cancer patients who did or did not pursue fertility preservationMolly B Moravek, Rafael Confino, Kristin N Smith, et al.
Oncotarget|October 6, 2017
Analyses of selected safety endpoints in phase 1 and late-phase clinical trials of anti-PD-1 and PD-L1 inhibitors: prediction of immune-related toxicitiesRicardo Costa, Rubens B Costa, Sarah M Talamantes, et al.
Clinical & Experimental Metastasis|June 14, 2012
The role of targeted therapy and biomarkers in breast cancer treatmentAlison T Stopeck, Ursa Brown-Glaberman, Hong Yuen Wong, et al.
Annals of Surgical Oncology|July 12, 2021
Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases: An NCDB AnalysisRoi Weiser, Efstathia Polychronopoulou, Waqar Haque, et al.
Pageof 20